ChemotherapyNCT07812532
Effect of Gamified Sun Protection Education Provided to Chemotherapy Patients
A study testing Gamified education in people with Chemotherapy and Sun Protection, run by Lokman Hekim University at 1 site in Turkey (Türkiye).
Trial summary
Chemotherapy may cause photosensitivity and other skin reactions that can negatively affect patients' comfort, quality of life, and adherence to treatment. Appropriate sun protection behaviors are therefore important for patients receiving chemotherapy. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Chemotherapy, Sun Protection, Self Efficacy
- What is being tested?
- Gamified education
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 54 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 30 Sep 2026to 30 Nov 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Currently receiving chemotherapy
- Aged 18 years or older
- No major mental disorder that may interfere with participation in the study
- No major visual, hearing, or communication impairment that may interfere with participation in the study
- Able to read and write in Turkish
- Willing to participate voluntarily in the study
- Able to use mobile applications and a smartphone
Who cannot join
- -Receiving radiotherapy concurrently with chemotherapy
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Turkey (Türkiye)1 site
Lokman Hekim University Ankara Hospital
Ankara
About this study
Official title: Effect of Gamified Sun Protection Education Provided to Chemotherapy Patients on Their Sun Protection Behaviors and Self-Efficacy
Chemotherapy may cause photosensitivity and other skin reactions that can negatively affect patients' comfort, quality of life, and adherence to treatment. Appropriate sun protection behaviors are therefore important for patients receiving chemotherapy.
This randomized controlled trial aims to evaluate the effect of gamified sun protection education on sun protection self-efficacy and sun protection behaviors in patients receiving chemotherapy.
Read more
A total of 54 patients will be randomly assigned to two groups, with 27 participants in each group. Participants in the intervention group will receive gamified sun protection education, while participants in the control group will receive usual care. The educational intervention will be delivered over a two-week period.
Sun protection self-efficacy and sun protection behaviors will be assessed at baseline and after completion of the two-week intervention.
- Conditions
- Chemotherapy, Sun Protection, Self Efficacy, Oncology Patients, Education, Gamification in Health Education
- Being tested
- Gamified education
- Keywords
- Sun protection, Oncology patients, Education, gamification, Chemotherapy, Gamification in health education, self efficiency
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Gamified educationBehavioural
Gamified education
| Study group | Role | What they receive |
|---|---|---|
| Intervention group | Experimental | Not described Receives: Behavioral: Gamified education |
| control group | No intervention | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Sun Protection Self-Efficacy Scale Total Score
Sun protection self-efficacy will be assessed using the Sun Protection Self-Efficacy Scale. The outcome will be the change in the total scale score from baseline to the end of the 2-week intervention. Higher scores indicate greater self-efficacy regarding sun protection behaviors.
Measured: Baseline and immediately after completion of the 2-week intervention
Secondary outcomes (1)
Change in Sun Protection Behavior Scale Total Score
Sun protection behaviors will be assessed using the Sun Protection Behavior Scale. The outcome will be the change in the total scale score from baseline to the end of the 2-week intervention. Higher scores indicate greater engagement in sun protection behaviors.
Measured: Baseline and immediately after completion of the 2-week intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Sep 2026
- Study start30 Sep 2026 (estimated)
- Primary completion30 Nov 2026 (estimated)
- Study completion30 Nov 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for ChemotherapyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 54 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Lokman Hekim University
- Sponsor type
- Other government
- Collaborators
- The Scientific and Technological Research Council of Turkey
- Responsible party
- Principal investigator, Esra Turker, Lokman Hekim University
- Investigators
- Esra Türker, Principal investigator, Lokman Hekim University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07812532
- Sponsor's protocol ID
- 2025328
- Other IDs
- 1919B012550663
- Status last verified
- Sep 2026
- First submitted
- 29 May 2026
- Last updated
- 10 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data (IPD) are not planned to be shared.
Study at a glance
From the registry record, last updated by the sponsor on 10 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Gamified Sun Protection Education Provided to Chemotherapy Patients on Their Sun Protection Behaviors and Self-Efficacy
- ClinicalTrials.gov ID
- NCT07812532
- Acronym / sponsor ID
- 2025328
- Conditions
- Chemotherapy, Sun Protection, Self Efficacy, Oncology Patients, Education, Gamification in Health Education
- Keywords
- Sun protection, Oncology patients, Education, gamification, Chemotherapy, Gamification in health education, self efficiency
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 54 participants (estimated)
- Lead sponsor
- Lokman Hekim UniversityOther government
- Collaborators
- The Scientific and Technological Research Council of Turkey
- Study start
- 30 Sep 2026 (estimated)
- Primary completion
- 30 Nov 2026 (estimated)
- Study completion
- 30 Nov 2026 (estimated)
- First posted
- 10 Sep 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Chemotherapy may cause photosensitivity and other skin reactions that can negatively affect patients' comfort, quality of life, and adherence to treatment. Appropriate sun protection behaviors are therefore important for patients receiving chemotherapy.
This randomized controlled trial aims to evaluate the effect of gamified sun protection education on sun protection self-efficacy and sun protection behaviors in patients receiving chemotherapy.
A total of 54 patients will be randomly assigned to two groups, with 27 participants in each group. Participants in the intervention group will receive gamified sun protection education, while participants in the control group will receive usual care. The educational intervention will be delivered over a two-week period.
Sun protection self-efficacy and sun protection behaviors will be assessed at baseline and after completion of the two-week intervention.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Intervention group | Experimental | Behavioral: Gamified education |
| control group | No intervention | – |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- Currently receiving chemotherapy
- Aged 18 years or older
- No major mental disorder that may interfere with participation in the study
- No major visual, hearing, or communication impairment that may interfere with participation in the study
- Able to read and write in Turkish
Key exclusion criteria (1 listed)
- -Receiving radiotherapy concurrently with chemotherapy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Gamified educationGamified education | Behavioural | Intervention group |
Primary outcome
Change in Sun Protection Self-Efficacy Scale Total Score
Time frame: Baseline and immediately after completion of the 2-week intervention
Sun protection self-efficacy will be assessed using the Sun Protection Self-Efficacy Scale. The outcome will be the change in the total scale score from baseline to the end of the 2-week intervention. Higher scores indicate greater self-efficacy regarding sun protection behaviors.
1 secondary outcome
Change in Sun Protection Behavior Scale Total Score
Time frame: Baseline and immediately after completion of the 2-week intervention
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Sep 2026.
- Individual participant dataSharing planned: No. Individual participant data (IPD) are not planned to be shared.
Related trials for Chemotherapy
RecruitingPhase 1/2
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
RecruitingObservational study
A Study in Children and, Adults With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Treated With Adzynma
Thrombotic Thrombocytopenic Purpura (TTP)
Active, not recruitingPhase 1/2
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
Multiple Myeloma
RecruitingPhase 3
A Study of Camrelizumab Plus Chemotherapy in Combination With or Without Famitinib as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (BCTOP-T-N01)
TNBC - Triple-Negative Breast Cancer
RecruitingPhase 3
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Esra Türker principal investigator
Lokman Hekim University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Gamified education in people with Chemotherapy and Sun Protection, run by Lokman Hekim University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 10 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Esra Türker, PhD (+905074521224, esra.turker@lokmanhekim.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Sun Protection Self-Efficacy Scale Total Score (time frame: Baseline and immediately after completion of the 2-week intervention). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Sep 2026.